Credit Suisse's Tesla Analyst Sees Buying Opportunity, Stands By 2016 Forecast
- Tesla Motors Inc (NASDAQ: TSLA) shares have declined 32.95 percent over the past six months, to a low of $162.60 on February 5.
- Dan Galves of Credit Suisse has maintained an Outperform rating on the company, with a price target of $325.
- Galves believes that concerns regarding the Model X ramp and volumes have been overdone and present a buying opportunity in the stock.
Analyst Dan Galves said that he remained “bullish on TSLA, with high conviction on a 12-month view and also constructive in front of Wednesday's print.”
However, the recent selloff in the stock was fueled by global macro concerns, negative sentiment on auto stock and falling oil prices, apart from the structural concerns regarding Model X.
“We don't really understand the repeated underestimation of Tesla's ability to deliver, and see this as an opportunity,” Galves pointed out, while noting that there had been similar concerns in the past regarding the Model S.
Although the Model X ramp has been slower than expected, this has not been due to fundamental issues, according to the Credit Suisse report, which also stated that it was Tesla Motors is likely to have achieved the production of 500 units in Q4 and continued deliveries in January/February.
“We believe that several minor but unacceptable quality issues existed on early production…the company slowed down the line to tweak the production process and, in some cases, to wait for re-designed parts,” Galves said.
Management noted that the production process was now on track, with no “critical unresolved design issues.” Once redesigned parts were available, management expects the ramp to proceed quickly.
The Q4 EPS estimate has been raised from $0.10 to $0.16, with expectations of total deliveries of more than 16,000 units in Q1 and over 80,000 in 2016.
Latest Ratings for TSLA
|Oct 2016||Goldman Sachs||Maintains||Neutral|
|Oct 2016||Goldman Sachs||Downgrades||Buy||Neutral|
|Sep 2016||Cowen & Co.||Initiates Coverage on||Underperform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.